MedTech Acquisition Corp
Completed 2023-08-10- CIK 1826667
- MTAC
- Now TLSI
- IPO 2020-12-21
- $12.1M trust
- 493 filings
Successfully merged with TriSalus Operating Life Sciences, Inc. • Now trading as TLSI
- IPO Size
- $250M
- raised at the IPO
- Trust
- $12.1M
- as of 2023-06-30
- Current Status
- Completed
- from its latest filing
- IPO Year
- 2020
- year it listed
Filings, by quarter
493 filings over 25 quarters; violet bars carry a milestone
- 20 Q4: 21 filings
- 21 Q1: 10 filings
- 21 Q2: 8 filings
- 21 Q3: 5 filings
- 21 Q4: 5 filings
- 22 Q1: 14 filings
- 22 Q2: 2 filings
- 22 Q3: 4 filings
- 22 Q4: 23 filings
- 23 Q1: 16 filings
- 23 Q2: 30 filings
- 23 Q3: 65 filings
- 23 Q4: 17 filings
- 24 Q1: 14 filings
- 24 Q2: 38 filings
- 24 Q3: 27 filings
- 24 Q4: 27 filings
- 25 Q1: 34 filings
- 25 Q2: 43 filings
- 25 Q3: 15 filings
- 25 Q4: 14 filings
- 26 Q1: 24 filings
- 26 Q2: 24 filings
- 26 Q3: 9 filings
- 26 Q4: 4 filings
- S-1 filed 20 Q4
- IPO 20 Q4
- Completed 23 Q3
SPAC Overview
Where it stands on the road from S-1 to merger
Timeline Progress
About
MedTech Acquisition Corporation is a blank-check company seeking to complete a business combination. It intends to focus on businesses primarily operating in the healthcare sector in the United States.
Investment Focus
Healthcare
Geographic Focus
United States
Key Information
As the filings state it
- IPO Date
- 2020-12-21
- Total Redemptions
- $250M
- PIPE
- $40.2M
- Jurisdiction of Incorporation
- Delaware
- SIC
- 6770
- Completion Date
- 2023-08-10
- Merger Target
- TriSalus Operating Life Sciences, Inc.
- SPAC Ticker
- MTAC
- Merged Ticker
- TLSI
Stock Performance
TLSITrading symbol, and its price at each step since the first trade
| Point | Date | Price | Move |
|---|---|---|---|
| First Trade | 2021-02-08 | $11.00 | |
| At Merger | 2023-08-11 | $12.00 | +9% |
| 6 Months Post-Merger | 2024-02-12 | $9.50 | -21% |
| 1 Year Post-Merger | 2024-08-12 | $5.84 | -51% |
| 2 Years Post-Merger | 2025-08-11 | $3.57 | -70% |
| Current Price | 2026-10-16 | $3.63 | -67% |
SPAC Team
The banks on its IPO, and the team as the filings describe it
Underwriters
Extended Team Information
The team includes healthcare executives and medical-technology entrepreneurs, operators and investors, with prior experience in healthcare companies, medical devices, public-company boards, private equity and investment management.